A Regulator-Ready Workflow for E&L Studies in Single-Use Bioreactor Systems

Key Takeaways

Modern E&L programs for bioprocessing focus on four critical pillars of safety and compliance:

• Regulatory compliance: E&L studies ensure patient safety and product quality in line with USP <665>, USP <1663>, and ICH Q3D requirements.
• Risk-based design: Successful studies start with a documented risk assessment and scientifically justified worst-case assumptions regarding solvent polarity and temperature.
• Orthogonal analytics: A combination of GC/MS (volatile/semi-volatile), LC/HRMS (non-volatile), and ICP-MS (elemental) is required to ensure no analytical blind spots.
• Data integration: Final reports must bridge the gap between analytical findings and toxicological risk by calculating the analytical evaluation threshold (AET) relative to the permitted daily exposure (PDE).

These takeaways emphasize the necessity of a multidisciplinary approach to material safety.

The Risk of Single-Use Systems (SUS)

Single-use bioreactor bags are the backbone of modern upstream bioprocessing, offering operational flexibility and reduced cleaning validation. However, these multilayer polymer films—often comprising ultra-low density polyotheine (ULDPE), ethylene vinyl alcohol (EVOH), and various tie layers—pose a risk: additives, monomers, and degradation products can migrate into process fluids. A robust extractables and leachables (E&L) program quantifies this risk and helps prevent impacts on cell culture productivity or clinical safety.

Regulatory Context and Safety Thresholds

Regulators (the Food and Drug Administration (FDA) and the European Medicines Agency (EMA)) require manufacturers to characterize contact materials using a risk-based approach. The analytical depth is often dictated by the component's proximity to the final drug product. Manufacturers must adhere to specific industry standards to meet these expectations:

• USP <665> & <1663>: Provides the framework for assessing plastic components in biomanufacturing and guidelines for assessment of extractables.
• ICH Q3D: Governs elemental impurities, requiring ICP-MS sensitivity down to parts-per-billion (ppb) levels.
• Analytical evaluation threshold (AET): A calculated concentration limit derived from the safety concern threshold (SCT), below which compounds do not require toxicological identification.

Adhering to these established benchmarks ensures that the data generated is suitable for global regulatory submissions.

Working in analytical science?

Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.

Subscribe for free

Study Design: Establishing the "Worst-Case"

A defensible study must align with BioPhorum Operations Group (BPOG) protocols or USP <665> standards to ensure global acceptance.

Selecting Extraction Solvents

Solvents must bracket the polarity of process media to ensure all potential migrants—from highly polar acids to non-polar antioxidants—are captured. Typical model solvents include:

• Low pH (0.1 M phosphoric acid): To mimic acidic conditions and catalyze certain polymer degradations.
• High pH (0.5 N NaOH): To simulate alkaline cleaning or high-pH storage environments.
• 50% ethanol/water: To simulate organic/lipophilic interactions common in media supplements or high-protein concentrations.
• Purified water/water for injection (WFI): As a neutral control to establish a baseline extraction profile.

By covering this range of polarities, the study provides a comprehensive chemical fingerprint of the material.

Exaggerated Conditions

Extractables studies drive migrants out using kinetic stress conditions that exceed standard operation to ensure "worst-case" profiling:

• Temperature: Typically 40°C for 21 days (BPOG) or 70°C for shorter durations to accelerate migration.
• Duration: Extended contact times ensure that slow-diffusing species from internal polymer layers (like tie-layer adhesives) reach the solvent.
• Surface area-to-volume ratio: A standard value of 6 cm²/mL is used to ensure the migrants' concentration is within the instrument's detectable range.

These exaggerated parameters ensure that the study identifies the maximum potential risk level before clinical use.

Orthogonal Analytical Techniques

For a separation science audience, the choice of stationary phases and ionization modes is critical for achieving the required selectivity and sensitivity.

This orthogonal suite ensures that regardless of a compound's volatility or polarity, it can be detected and quantified.

Preventing Laboratory Artifacts

Data integrity relies on distinguishing material-derived peaks from background noise, particularly when working at the trace levels required by the AET. The following controls are standard in high-quality E&L programs:

• Method blanks: Essential for identifying "ghost peaks" from solvent impurities or septa bleed.
• Negative controls: Utilizing borosilicate glass or fluoropolymer vessels to avoid leaching from standard plastic labware.
• System suitability: Monitoring peak tailing factors and signal-to-noise ratios (S/N > 10) for internal standards.

Implementing these rigorous controls prevents the reporting of false positives that can lead to unnecessary and costly project delays.

Data Interpretation and Risk Assessment

The transition from a "chromatographic peak" to a "safety conclusion" requires high-resolution data and sophisticated library matching.

Identification Confidence Levels

The certainty of an identification is categorized based on the available spectral and chromatographic evidence:

1. Confirmed: Mass spectrum and retention time match an authentic reference standard injected on the same system.

2. Confident: High-quality match (>80%) in commercial libraries (NIST) combined with accurate mass and isotopic pattern fit.

3. Tentative: Molecular formula and structural fragments assigned via MS/MS (product ion scanning) without standard verification. This tiered approach allows toxicologists to prioritize assessment based on the reliability of the chemical data.

Toxicological Evaluation

Once identified, compounds are compared against established benchmarks to determine clinical safety:

• Threshold of toxicological concern (TTC): A default value (typically 1.5 µg/day) applied when no specific toxicity data exists.
• Permitted daily exposure (PDE): A compound-specific limit derived from chronic toxicity studies, adjusted for uncertainty factors.
• Margin of safety (MoS): The ratio of the PDE to the estimated daily intake (EDI) based on clinical dosage. The ultimate goal of this evaluation is to demonstrate that the presence of any migrant is well within safe clinical limits.

Regulatory Reporting Requirements

A regulator-ready report should be structured for transparency and ease of review. Key sections of a comprehensive report include:

• Executive summary: A high-level conclusion on the safety of the single-use system for its intended use.
• Analytical methodology: Detailed descriptions of instrument settings, including gradient profiles and ionization parameters.
• AET derivation: A clear mathematical justification for the reporting threshold used during the study.
• Tabulated results: A comprehensive list of all migrants above the AET, including their identification confidence and safety margins.

A well-organized report streamlines the review process and reduces the likelihood of health authorities asking clarifying questions.

Conclusion

As biomanufacturing trends toward continuous processing, the complexity of SUS increases. A structured E&L workflow—built on BPOG/USP guidelines and high-resolution analytical chemistry—transforms material uncertainty into managed variables. This proactive approach ensures that the advantages of SUS never come at the cost of patient safety.